Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol versus dexmedetomidine for ICU agitation and delirium
ChiCTR2200062799Phase 3Not yet recruiting
- Sponsor
- Dalian Municipal Central Hospital
- Start
- Jan 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in delirium comparing Ciprofol group with Dexmedetomidine group (2 arms). Primary endpoints: Sedation success rate and Short-term mortality. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
ciprofoldexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on ChiCTR2200062799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062799.